Samsung says South Korea’s Ministry of Food and Drug Safety has approved its Galaxy Buds hearing-test and hearing-aid software as digital medical devices. The company announced the decision on 4 November, with a gradual Korean release planned for early 2027. The announcement concerns software for Galaxy Buds3 Pro and Buds4 Pro, rather than a new earbud model.
The distinction between permission and availability matters. Samsung’s Korean statement describes a future software update, not a feature already switched on for every owner. It also does not announce a Nigerian release. Buying either named model in Nigeria therefore cannot, on the evidence of this announcement, be treated as confirmation that these hearing functions will work locally.
According to Samsung, the test presents tones to each ear separately and produces a hearing profile. The hearing-aid function then adjusts amplification using that profile. The company describes the intended users as adults aged 18 and above with perceived mild to moderate hearing loss. Those limits do not describe a product for children or every degree of hearing difficulty.
This is a separate regulatory development from Samsung’s United States announcement on 11 August. That earlier release said the hearing-aid feature had received US Food and Drug Administration clearance and proposed availability in the United States and selected approved markets in the fourth quarter of 2026. It also specified a compatible Galaxy device with One UI 9 or later for full support.
What it means for you: a Nigerian buyer comparing earbuds for hearing support needs a local feature-availability answer as well as a hardware specification. The useful questions are whether the precise model, paired phone and country are supported, and when the relevant software is actually released. A foreign approval and a promised update are different pieces of information; neither alone settles all those questions.
Samsung’s own US notice says the hearing-aid feature is not a substitute for diagnosis or treatment by a qualified clinician. Wahala Today has not independently tested its clinical performance or confirmed Nigerian authorisation. The verified news here is the manufacturer’s dated account of Korean approval and its release plan, with those boundaries preserved rather than a claim that earbuds cure hearing loss.